Stock Chart
TVTX
Type: SELL growth_1yr
Strike: $28
Premium: $8.30
Expiry: Jan 15, 2027
Target: $24
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About TVTX - Travere Therapeutics, Inc. Common Stock
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
Key Statistics
More TVTX Analysis
This TVTX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TVTX's price movements with trendlines, gamma walls, and key support/resistance levels.